About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Medicine-induced Cardiac Hemodialysis on COVID-19 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT05711810

Medicine-induced Cardiac Hemodialysis on COVID-19

The clinical trial studies the human pathogen of SARS-CoV-2, with a specificity in the circulating Spike 2 protein in the human system. The clinical trial hypothesizes that SARS-CoV-2 human pathogen a...

Lead sponsor: Yang I. Pachankis•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Yang I. Pachankis

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•No mRNA vaccinated poisoning have been included currently, but scientific evidence suggest the methods of vaccination are irrelevant to the conditions. It is theorized that the more advanced the vaccine production technology, the deeper the poisoning.

Exclusion Criteria

•healthy individuals with no myocarditis or unvaccinated without infection by SARS-CoV series
•persons with diabetes (Paxlovid and PrEP treatments can be applied according to availability)

Related studies

Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis

NCT06376968 · Renal Dialysis

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

NCT06535139 · Papillomavirus Vaccines

RECRUITINGPhase 4

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

NCT05266898 · Papillomavirus Vaccines, Human Immunodeficiency Virus, and more

Toxicokinetics of Protein-bound Uremic Toxins in ESRD Patients

NCT05755503 · Uremic; Toxemia, Pharmacokinetics, and more

Reminder Emails to Improve Pneumococcal Vaccine Completion at 12 Months of Age

NCT06000397 · Pneumococcal Vaccines, Immunization Coverage

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 3, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment1

Start dateJan 2023

Last updatedFeb 3, 2023

Condition

Severe Acute Respiratory Syndrome-related Coronavirus Renal Dialysis Vaccines Myocarditis Allergic Infection Viral

Locations shown

Residential Address

Chongqing, Chongqing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 3, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions